|
|
Agenix Limited - Price Analysis Snapshot
This Report features up to a ten-year record of the equity Price history for Agenix Limited. Tabular results include the High, Low and Closing price for the quarter. There is also a calculation of percentage change in price for both Quarterly and Annual periods. Price values are adjusted for stock splits and dividends.
Agenix Limited. The Group's principal activities are carried out through the following business segments: Monoclonal antibody development, which develops monoclonal antibody-based products; Molecular biology, which manufactures and sells biomedical products; and Agenix Biopharmaceuticals, which develops, manufactures and sells pharmaceutical products. Its core businesses are located in Australia with the manufacturing and distribution business segment having operations in the People's Republic of China. It maintains an office in Singapore and has certain operations in the United States of America.
Not the Report you are looking for? Click here for more browsing options.
Layout and Content of a Typical Report
|
|
|
|
|